Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,760
datasets available to search
ShareScore release 0.9.0
Dataset results
1,760 results for “phase 2”
CREATE: Cross-tumoral Phase 2 With Crizotinib
ClinicalTrials.gov study NCT01524926. IPD Sharing: Not stated. Countries: 10. Publications: 5.
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
ClinicalTrials.gov study NCT05016219. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Virtual Physical Activity Seated Exercise - Phase 2
ClinicalTrials.gov study NCT05724823. IPD Sharing: NO. Countries: 1. Publications: 1.
Feedback to Improve Rational Strategies of Antibiotic Initiation and Duration in Long Term Care (FIRST AID -LTC) - Phase 2
ClinicalTrials.gov study NCT04187742. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT00892931. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
ClinicalTrials.gov study NCT03944772. IPD Sharing: YES. Countries: 9. Publications: 3.
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
ClinicalTrials.gov study NCT07189793. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)
ClinicalTrials.gov study NCT04961359. IPD Sharing: NO. Countries: 1. Publications: 1.
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
ClinicalTrials.gov study NCT00198393. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NSCLC
ClinicalTrials.gov study NCT04636593. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1 Follow-on Study of AAV2-hRPE65v2 Vector in Subjects With Leber Congenital Amaurosis (LCA) 2
ClinicalTrials.gov study NCT01208389. IPD Sharing: NO. Countries: 1. Publications: 6.
MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
ClinicalTrials.gov study NCT00837577. IPD Sharing: YES. Countries: 0. Publications: 1.
UNIty-Based MR-Linac Guided AdapTive RadiothErapy for High GraDe Glioma: a Phase 2 Trial
ClinicalTrials.gov study NCT04726397. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia
ClinicalTrials.gov study NCT00664014. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients
ClinicalTrials.gov study NCT00511459. IPD Sharing: Not stated. Countries: 13. Publications: 1.
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
ClinicalTrials.gov study NCT01725256. IPD Sharing: Not stated. Countries: 3. Publications: 58.
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial
ClinicalTrials.gov study NCT04118699. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction
ClinicalTrials.gov study NCT01977755. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
ClinicalTrials.gov study NCT02368951. IPD Sharing: Not stated. Countries: 3. Publications: 1.
PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19
ClinicalTrials.gov study NCT04784767. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.